Both genetic and pharmacological blockade of TRPA1 indicate its probable contribution to mild hypoxia-induced respiratory excitation and, to a lesser extent, hyperoxia-induced respiratory depression. The gene discussed is TRPA1; the disease is Respiratory insufficiency due to muscle weakness.